Filing Details

Accession Number:
0001209191-18-061104
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-12-06 08:05:23
Reporting Period:
2018-12-03
Accepted Time:
2018-12-06 08:05:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1008848 Acorda Therapeutics Inc ACOR Biological Products, (No Disgnostic Substances) (2836) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1607965 A. Andrew Hindman 420 Saw Mill River Road
Ardsley NY 10502
Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-12-03 753 $20.56 5,171 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Sales pursuant to a 10b5-1 plan. These sales are primarily intended to cover the tax liability resulting from restricted stock vesting.